Roser Pinyol

Also affiliated with Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Universitat de Barcelona

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 18 papers. Top paper: “CXCR2 inhibition enables NASH-HCC immunotherapy”.

CXCR2 inhibition enables NASH-HCC immunotherapy

Gut(2022)10.1136/gutjnl-2021-326259

N/A

4.8DataRank · unranked

230 citations

John B. G. Mackey, Thomas Jamieson, Erik Ramon‐Gil, Thomas M. Drake, Frédéric Fercoq +41 more

E7386 Enhances Lenvatinib’s Antitumor Activity in Preclinical Models and Human Hepatocellular Carcinoma

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-0725

N/A

0.282DataRank · unranked

5 citations

Albert Gris‐Oliver, Ugne Balaseviciute, Alka A. Potdar, Takayuki Kimura, Jialing Shen +21 more

Molecular pathogenesis and systemic therapies for hepatocellular carcinoma

Nature Cancer(2022)10.1038/s43018-022-00357-2

N/A

0DataRank · unranked

490 citations

Roser Pinyol, Robin Kate Kelley, Anthony B. El-Khoueiry, Helen L. Reeves, Sophie Wang +3 more

Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-2517

N/A

0DataRank · unranked

78 citations

Catherine E. Willoughby, Marta Piqué-Gili, Carla Montironi, Jordi Abril‐Fornaguera, Judit Peix +8 more

CXCR2 inhibition enables NASH-HCC immunotherapy

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.02.24.481779

N/A

0DataRank · unranked

3 citations

John B. G. Mackey, Thomas Jamieson, Erik Ramon‐Gil, Thomas M. Drake, Frédéric Fercoq +41 more

Identification of IGF2 as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma

Molecular Cancer Therapeutics(2023)10.1158/1535-7163.mct-22-0335

N/A

0DataRank · unranked

15 citations

Laura Torrens, Carmen Andreu-Oller, Juan Carrillo-Reixach, Alexander Rialdi, Ugne Balaseviciute +24 more

Supplementary Figure from Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma

INDIGO (University of Illinois at Chicago)(2023)10.1158/1078-0432.22482765.v1

N/A

0DataRank · unranked

0 citations

Catherine E. Willoughby, Marta Piqué‐Gili, Carla Montironi, Jordi Abril‐Fornaguera, Judit Peix +8 more

Data from Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma

(2023)10.1158/1078-0432.c.6530994

N/A

0DataRank · unranked

0 citations

Catherine E. Willoughby, Marta Piqué‐Gili, Carla Montironi, Jordi Abril‐Fornaguera, Judit Peix +8 more

Data from Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma

(2023)10.1158/1078-0432.c.6530994.v1

N/A

0DataRank · unranked

0 citations

Catherine E. Willoughby, Marta Piqué‐Gili, Carla Montironi, Jordi Abril‐Fornaguera, Judit Peix +8 more

Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma

Nature Reviews Clinical Oncology(2024)10.1038/s41571-024-00868-0

N/A

0DataRank · unranked

346 citations

Roser Pinyol, Mark Yarchoan, Amit G. Singal, Thomas U. Marron, Myron E. Schwartz +4 more

Single-cell RNA sequencing-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinoma

Journal of Hepatology(2024)10.1016/j.jhep.2024.12.016

N/A

0DataRank · unranked

44 citations

Marta Piqué‐Gili, Roger Esteban-Fabró, Gino Philips, Ugne Balaseviciute, Roser Pinyol +36 more

Hepatocellular carcinoma hosts cholinergic neural cells and tumoral hepatocytes harboring targetable muscarinic receptors

JHEP Reports(2024)10.1016/j.jhepr.2024.101245

N/A

0DataRank · unranked

8 citations

Claire Verzeroli, Armando Andres Roca Suarez, Abud-José Farca-Luna, Laurie Tonon, Roger Esteban-Fabró +20 more

Oncogenic role of PMEPA1 and its association with immune exhaustion and TGF-β activation in HCC

JHEP Reports(2024)10.1016/j.jhepr.2024.101212

N/A

0DataRank · unranked

5 citations

Carmen Andreu-Oller, Agavni Mesropian, Roger Esteban-Fabró, Marina Bárcena‐Varela, Marina Ruiz de Galarreta +19 more

Artificial intelligence predicts outcome-related molecular profiles and vascular invasion in hepatocellular carcinoma

JHEP Reports(2025)10.1016/j.jhepr.2025.101592

N/A

0DataRank · unranked

3 citations

Agavni Mesropian, Laura Žigutytė, James Brooks, Ezequiel Mauro, Albert Gris‐Oliver +13 more

Molecular insights into early malignant transition of hepatocellular carcinoma

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.04.14.648739

N/A

0DataRank · unranked

0 citations

H. Li, Lingli Chen, Tao Lü, Xinyi Shentu, Yuanhua Liu +15 more

Liver Injury Increases the Incidence of HCC following AAV Gene Therapy in Mice

Molecular Therapy(2020)10.1016/j.ymthe.2020.10.018

N/A

0DataRank · unranked

104 citations

Laura Torrens, Jordi Abril‐Fornaguera, Roser Pinyol, Catherine E. Willoughby, Jeffrey Posey +6 more

Effective therapeutic targeting of CTNNB1 ‐mutant hepatoblastoma with WNTinib

Molecular Oncology(2025)10.1002/1878-0261.70168

N/A

0DataRank · unranked

0 citations

Júlia Huguet‐Pradell, Jordi Abril‐Fornaguera, Albert Gris‐Oliver, Alex Rialdi, Elisa Fernández‐Martínez +13 more

Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis

Journal of Hepatology(2021)10.1016/j.jhep.2021.04.049

N/A

0DataRank · unranked

234 citations

Sara Torrecilla, Huan Wang, Carla Montironi, Marta Piqué‐Gili, Miguel Torres‐Martín +30 more